Bio Protocol
@bioprotocol.bsky.social
Biotech's new financial layer. Coin your science on Bio Protocol. Fund your research now → bio.xyz/scientists
We’ll walk through how launching on Bio works and how decentralized science can offer a faster, easier path to biotech funding and R&D.
RSVP now: luma.com/launchwithbio
RSVP now: luma.com/launchwithbio
How to Build & Fund Decentralized Research Projects with Bio · Luma
Join us next THURSDAY for a livestream exploring how to fund and coordinate your research with Bio Protocol.
James Sinka, Bio’s Chief Science Officer, will…
luma.com
October 30, 2025 at 10:59 AM
We’ll walk through how launching on Bio works and how decentralized science can offer a faster, easier path to biotech funding and R&D.
RSVP now: luma.com/launchwithbio
RSVP now: luma.com/launchwithbio
Fund your research with Bio: bio.xyz/scientists
Or refer a researcher who launches on Bio and earn 20K $BIO as a referral fee.
Or refer a researcher who launches on Bio and earn 20K $BIO as a referral fee.
Launch With Bio
Bio Protocol is your dedicated partner in a journey of scientific collaboration and funding. All you need is a vision and scientific expertise.
bio.xyz
October 25, 2025 at 8:43 AM
Fund your research with Bio: bio.xyz/scientists
Or refer a researcher who launches on Bio and earn 20K $BIO as a referral fee.
Or refer a researcher who launches on Bio and earn 20K $BIO as a referral fee.
For researchers, this is what becomes possible with fast access to capital, minimal overhead, a direct path from discovery to clinic, and transparent IP ownership.
If you are building in science, start here: www.bio.xyz/scientists
If you are building in science, start here: www.bio.xyz/scientists
Launch With Bio
Bio Protocol is your dedicated partner in a journey of scientific collaboration and funding. All you need is a vision and scientific expertise.
www.bio.xyz
October 23, 2025 at 2:53 PM
For researchers, this is what becomes possible with fast access to capital, minimal overhead, a direct path from discovery to clinic, and transparent IP ownership.
If you are building in science, start here: www.bio.xyz/scientists
If you are building in science, start here: www.bio.xyz/scientists
Bio made it possible to protect discoveries and involve patients directly.
IP stays in the hands of families through anti-shelving provisions, with 120+ rare disease groups connected via CombinedBRAIN.
IP stays in the hands of families through anti-shelving provisions, with 120+ rare disease groups connected via CombinedBRAIN.
October 23, 2025 at 2:53 PM
Bio made it possible to protect discoveries and involve patients directly.
IP stays in the hands of families through anti-shelving provisions, with 120+ rare disease groups connected via CombinedBRAIN.
IP stays in the hands of families through anti-shelving provisions, with 120+ rare disease groups connected via CombinedBRAIN.
The AARS2 rare disease program shows what happens when science becomes lean and transparent.
Two new drug targets discovered for under $100K in total research costs, completed within months.
Both targets are now minted as IP-NFTs, and next-generation drug screenings are underway.
Two new drug targets discovered for under $100K in total research costs, completed within months.
Both targets are now minted as IP-NFTs, and next-generation drug screenings are underway.
October 23, 2025 at 2:53 PM
The AARS2 rare disease program shows what happens when science becomes lean and transparent.
Two new drug targets discovered for under $100K in total research costs, completed within months.
Both targets are now minted as IP-NFTs, and next-generation drug screenings are underway.
Two new drug targets discovered for under $100K in total research costs, completed within months.
Both targets are now minted as IP-NFTs, and next-generation drug screenings are underway.
• $1.8M raised in February 2025
• Ten new drug screens completed
• IP-NFTs minted and patents filed
• N-of-1 clinical studies now launching
“Very excited to have converted that 100K into several clinical candidates,” said Dr. Perlstein at DeSci Berlin.
• Ten new drug screens completed
• IP-NFTs minted and patents filed
• N-of-1 clinical studies now launching
“Very excited to have converted that 100K into several clinical candidates,” said Dr. Perlstein at DeSci Berlin.
October 23, 2025 at 2:53 PM
• $1.8M raised in February 2025
• Ten new drug screens completed
• IP-NFTs minted and patents filed
• N-of-1 clinical studies now launching
“Very excited to have converted that 100K into several clinical candidates,” said Dr. Perlstein at DeSci Berlin.
• Ten new drug screens completed
• IP-NFTs minted and patents filed
• N-of-1 clinical studies now launching
“Very excited to have converted that 100K into several clinical candidates,” said Dr. Perlstein at DeSci Berlin.
In traditional science, years often pass between an idea and the first experiment.
With Curetopia, Ethan is proving how Bio enables faster funding, leaner operations, and parallel progress across several clinical programs.
With Curetopia, Ethan is proving how Bio enables faster funding, leaner operations, and parallel progress across several clinical programs.
October 23, 2025 at 2:53 PM
In traditional science, years often pass between an idea and the first experiment.
With Curetopia, Ethan is proving how Bio enables faster funding, leaner operations, and parallel progress across several clinical programs.
With Curetopia, Ethan is proving how Bio enables faster funding, leaner operations, and parallel progress across several clinical programs.
📚 Read the weekly report now: www.bio.xyz/blog-posts/b...
Bio Weekly: $6.9M Raise, New Ignition Sales, DeSci Lending w/ Aave, RNA Molecules, Aubrai Nets $275K • BIO Resources
This week’s highlights: $6.9M Raise anchored by Arthur Hayes, new Ignition Sales and BIO lending on Aave V3.
www.bio.xyz
September 22, 2025 at 5:45 AM
📚 Read the weekly report now: www.bio.xyz/blog-posts/b...
> Aubrai, the first BioAgent, recently crossed $275K in monthly research funding generated from market-making fees in the $AUBRAI token. Funding is directed to the lab of Dr. @aubreydegrey.bsky.social and its ongoing RMR2 Life Extension study feeding data into the agent.
+ much more!
+ much more!
September 22, 2025 at 5:45 AM
> Aubrai, the first BioAgent, recently crossed $275K in monthly research funding generated from market-making fees in the $AUBRAI token. Funding is directed to the lab of Dr. @aubreydegrey.bsky.social and its ongoing RMR2 Life Extension study feeding data into the agent.
+ much more!
+ much more!
🧪 Submit your hypotheses: docs.google.com/forms/d/e/1F...
Research Proposal Submission Form
Please fill out this form to submit your research proposal.
Evaluation and Selection
Proposals will be reviewed by VitaDAO and Bio, with final selections determined by Aubrey de Grey at his sole discr...
docs.google.com
September 18, 2025 at 9:25 AM
🧪 Submit your hypotheses: docs.google.com/forms/d/e/1F...
Know someone who might be interested in submitting a research proposal? They could be student, medical professional or independent researcher.
Pass along this opportunity, have them reference you in the form below, and if their hypothesis is selected, you get paid 20K $BIO tokens.
Pass along this opportunity, have them reference you in the form below, and if their hypothesis is selected, you get paid 20K $BIO tokens.
September 18, 2025 at 9:25 AM
Know someone who might be interested in submitting a research proposal? They could be student, medical professional or independent researcher.
Pass along this opportunity, have them reference you in the form below, and if their hypothesis is selected, you get paid 20K $BIO tokens.
Pass along this opportunity, have them reference you in the form below, and if their hypothesis is selected, you get paid 20K $BIO tokens.
► Use Aubrai on X to create and refine a longevity hypothesis
► Best hypotheses are selected by @aubreydegrey.bsky.social and qualify for up to $100K in funding
► 20K $BIO bounty for referring researchers whose hypotheses get selected
► Best hypotheses are selected by @aubreydegrey.bsky.social and qualify for up to $100K in funding
► 20K $BIO bounty for referring researchers whose hypotheses get selected
September 18, 2025 at 9:25 AM
► Use Aubrai on X to create and refine a longevity hypothesis
► Best hypotheses are selected by @aubreydegrey.bsky.social and qualify for up to $100K in funding
► 20K $BIO bounty for referring researchers whose hypotheses get selected
► Best hypotheses are selected by @aubreydegrey.bsky.social and qualify for up to $100K in funding
► 20K $BIO bounty for referring researchers whose hypotheses get selected